1. Home
  2. KMDA vs EVTL Comparison

KMDA vs EVTL Comparison

Compare KMDA & EVTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KMDA
  • EVTL
  • Stock Information
  • Founded
  • KMDA 1990
  • EVTL 2016
  • Country
  • KMDA Israel
  • EVTL United Kingdom
  • Employees
  • KMDA N/A
  • EVTL N/A
  • Industry
  • KMDA Biotechnology: Pharmaceutical Preparations
  • EVTL Aerospace
  • Sector
  • KMDA Health Care
  • EVTL Industrials
  • Exchange
  • KMDA Nasdaq
  • EVTL Nasdaq
  • Market Cap
  • KMDA 443.4M
  • EVTL 467.9M
  • IPO Year
  • KMDA N/A
  • EVTL N/A
  • Fundamental
  • Price
  • KMDA $7.72
  • EVTL $6.96
  • Analyst Decision
  • KMDA Strong Buy
  • EVTL Strong Buy
  • Analyst Count
  • KMDA 2
  • EVTL 7
  • Target Price
  • KMDA $13.00
  • EVTL $10.83
  • AVG Volume (30 Days)
  • KMDA 55.4K
  • EVTL 2.9M
  • Earning Date
  • KMDA 08-13-2025
  • EVTL 08-05-2025
  • Dividend Yield
  • KMDA 2.59%
  • EVTL N/A
  • EPS Growth
  • KMDA 31.21
  • EVTL N/A
  • EPS
  • KMDA 0.28
  • EVTL N/A
  • Revenue
  • KMDA $167,235,000.00
  • EVTL N/A
  • Revenue This Year
  • KMDA $14.51
  • EVTL N/A
  • Revenue Next Year
  • KMDA $9.31
  • EVTL N/A
  • P/E Ratio
  • KMDA $28.31
  • EVTL N/A
  • Revenue Growth
  • KMDA 11.83
  • EVTL N/A
  • 52 Week Low
  • KMDA $5.08
  • EVTL $2.76
  • 52 Week High
  • KMDA $9.16
  • EVTL $15.99
  • Technical
  • Relative Strength Index (RSI)
  • KMDA 53.97
  • EVTL 58.40
  • Support Level
  • KMDA $7.64
  • EVTL $6.19
  • Resistance Level
  • KMDA $7.91
  • EVTL $6.76
  • Average True Range (ATR)
  • KMDA 0.18
  • EVTL 0.51
  • MACD
  • KMDA -0.02
  • EVTL 0.08
  • Stochastic Oscillator
  • KMDA 50.00
  • EVTL 78.31

About KMDA Kamada Ltd.

Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, the Proprietary Products segment and the Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.

About EVTL Vertical Aerospace Ltd.

Vertical Aerospace Ltd is engaged in making air travel personal, on-demand, and carbon-free. The company is a world-wide aerospace and technology company that is pioneering electric aviation, focused on designing, manufacturing, and selling a zero operating emission eVTOL aircraft for use in the AAM market, using the technology from the aerospace, automotive, and energy industries. The VX4, Vertical's flagship aircraft, is a piloted electric vertical take-off and landing (eVTOL) vehicle capable of carrying four passengers. The Group operates as a single operating segment and one reporting segment, being the development and commercialization of eVTOL technology.

Share on Social Networks: